Growth and Tolerance of Healthy Term Infants to a New Infant Formula

Healthy Term Infants Clinical Trial

Official title:
Growth and Tolerance of Healthy Term Infants to a New Infant Formula

Status Terminated

Clinical Trial Summary

The objective of this study is to evaluate the effect of two experimental milk-based infant formulas on the growth and gastrointestinal (GI) tolerance of term infants.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Healthy Term Infants

Clinical Trial Details

NCT number	NCT01137877
Study type	Interventional
Source	Abbott Nutrition
Contact
Status	Terminated
Phase	Phase 3
Start date	May 2010
Completion date	October 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02646969` - Growth and Metabolic Biomarkers of Healthy Term Infants Fed Formulas With Staged Protein Concentrations Over the First Year of Life	N/A
Completed	`NCT01155414` - Tolerance of Healthy Term Infants Fed Infant Formulas #4	Phase 3
Completed	`NCT04015050` - Randomised, Controlled Study to Assess Safety and Tolerance of Infant Formula With Prebiotics and Postbiotics in Healthy Infants.	N/A
Completed	`NCT01497314` - Growth and Safety of a Low Lactose Milk-Based Infant Formula	N/A
Terminated	`NCT02221687` - The Combiotic-Study	N/A
Completed	`NCT00712608` - The Evaluation of Cow's Milk Formula - Study B	N/A